Moonlake Immunotherapeutics · NASDAQ:MLTX

Bodenstedt Matthias sold 39,120 Moonlake Immunotherapeutics shares (Form 4)

Traded Jun 22, 2026 · Filed Jun 23, 2026

On Jun 22, 2026, Bodenstedt Matthias (Chief Financial Officer) sold 39,120 Moonlake Immunotherapeutics shares at US$22.04 for US$862K under a trading plan, leaving 1,115,435 shares. Filed Jun 23, 2026 (Form 4).

Sold
39,120 shares
Price
US$22.04
Value
US$862K
Holding after
1,115,435 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Class A ordinary shares, par value $0.0001 per shareSale39,120US$22.041,115,435Direct

Source

View original at SEC

Related